GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel BlockersDong Li, Marni J. Falk, Hongjie Yuan et al.|The American Journal of Human Genetics|2016Cited by 183
A second cohort of CHD3 patients expands the molecular mechanisms known to cause Snijders Blok-Campeau syndromeTheodore G. Drivas, Lot Snijders Blok, Alyssa Blesson et al.|European Journal of Human Genetics|2020Cited by 52
Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variantsSayaka Kayumi, Servi J.C. Stevens, Luis A. Pérez‐Jurado et al.|Genetics in Medicine|2022Cited by 50
Extension of the mutational and clinical spectrum of <i>SOX2</i> related disorders: Description of six new cases and a novel association with suprasellar teratomaPatrick R. Blackburn, Juan Carlos Zenteno, Oscar F. Chacón‐Camacho et al.|American Journal of Medical Genetics Part A|2018Cited by 11
Clinical features and genotype–phenotype correlations in epilepsy patients with de novo <scp><i>DYNC1H1</i></scp> variantsClaudia Cuccurullo, Hormos Salimi Dafsari, Emanuele Cerulli Irelli et al.|Epilepsia|2024Cited by 7